Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-12-08Clinical Trial Update: Tolerance of "on Line" Hemodiafiltration in Chronic Renal Failure Patients [Phase 4]
Phase 4 study update on tolerability of online hemodiafiltration in chronic kidney disease patients, with cardiovascular disease listed amon…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Effects of Intradialytic Exercise as Assessed by Bioimpedance Analysis and Blood Volume Monitoring [NA]
Completed clinical trial evaluating the effects of intradialytic exercise on bioimpedance measurements and blood volume monitoring in patien…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Clinical Trial to Compare Effectiveness of Diuretics in Hemodialysis Patients With Residual Renal Function [Phase 4]
A Phase 4 trial is investigating the effectiveness of diuretics in hemodialysis patients with residual renal function.
-
CLINICAL_TRIALS research · 2014-12-02Clinical Trial Update: Circulating lncRNA and CV Morbidities in CKD and ESRD
This clinical trial update describes a study on circulating long non-coding RNA and cardiovascular morbidities in patients with chronic kidn…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease [Phase 4]
This clinical trial update compares the effects of valsartan versus perindopril on the HOMA-IR index in patients with chronic kidney disease…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-11-26FDA Approved: SEVELAMER HYDROCHLORIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Sevelamer Hydrochloride by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2014-11-26FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Sevelamer carbonate (Renvela), a phosphate binder used to control hyperphosphatemia in chronic k…
-
FDA approval · 2014-11-26FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Renvela (sevelamer carbonate) submitted by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2014-11-25Clinical Trial Update: Study Design of 'Influence of Sarpogrelate in Patients With Renal Impairment or Diabetes Mellitus' Study [Phase 3]
Phase 3 study design update evaluating sarpogrelate in patients with coronary artery disease who have renal impairment or diabetes mellitus;…
-
CLINICAL_TRIALS trial_result · 2014-11-24Clinical Trial Update: Risk of Central Venous Stenosis in Patients With Chronic Renal Failure After IJ Line Placement
This clinical trial update discusses the risk of central venous stenosis in patients with chronic kidney disease after internal jugular cath…
-
CLINICAL_TRIALS research · 2014-11-21Clinical Trial Update: The Effects of Dietary Fiber in CKD: A Systematic Review and Meta-analysis
This document presents a systematic review and meta-analysis on the effects of dietary fiber in chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2014-11-19Clinical Trial Update: Hydroxychloroquine in Cardiovascular Disease in Patients With Chronic Kidney Disease: A Proof of Concept Study [Phase 2]
Phase 2 proof-of-concept study evaluating hydroxychloroquine for cardiovascular disease in patients with chronic kidney disease was terminat…
-
FDA approval · 2014-11-18FDA Approved: PARICALCITOL — Original Application (West-Ward Pharmaceuticals Corp)
FDA approved paricalcitol under an original NDA from West-Ward Pharmaceuticals Corp for the management of secondary hyperparathyroidism in a…
-
CLINICAL_TRIALS trial_result · 2014-11-17Clinical Trial Update: Restenosis Following Paclitaxel Eluting Balloon Angioplasty of Hemodialysis Access Stenosis [Phase 2]
Phase 2 trial of paclitaxel-eluting balloon angioplasty to prevent restenosis in hemodialysis access stenosis has completed. The study enrol…
-
FDA approval · 2014-11-15FDA Approved: FERRIC CITRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Ferric Citrate by Mylan Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2014-11-13Clinical Trial Update: A Phase III Study of PA21 in Peritoneal Dialysis Patients With Hyperphosphatemia [Phase 3]
Phase III study PA21 in peritoneal dialysis patients with hyperphosphatemia has completed, with the trial status updated.
-
CLINICAL_TRIALS trial_result · 2014-11-13Clinical Trial Update: Carvedilol and Micro T-Wave Alternans in Hypertensives With Chronic Kidney Disease [NA]
Terminated clinical trial at University of Toledo Health Science Campus evaluating carvedilol for micro T-wave alternans in hypertensive pat…
-
CLINICAL_TRIALS trial_result · 2014-11-07Clinical Trial Update: Vitamin D Insufficiency and Deficiency in Chronic Kidney Disease (CKD) Patients in Singapore
The National University of Singapore conducted a trial evaluating vitamin D insufficiency and deficiency in stage 2-5 chronic kidney disease…
-
CLINICAL_TRIALS trial_result · 2014-11-06Clinical Trial Update: Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease [Phase 2]
Phase 2 safety study of CTA018 injection for Stage 5 chronic kidney disease has completed. The trial targeted patients with secondary hyperp…
-
CLINICAL_TRIALS research · 2014-11-06Clinical Trial Update: Correlation Between Access Blood Flow and Extracorporeal Blood Flow
Clinical trial update exploring the relationship between vascular access (arteriovenous fistula) blood flow and extracorporeal blood flow in…
-
CLINICAL_TRIALS research · 2014-11-05Clinical Trial Update: Omega-3 Acids and Cardio - Vascular Complications in Patients With Chronic Kidney Disease in Stage 1-3 [NA]
This clinical trial update concerns omega-3 fatty acids for reducing vascular complications in adults with chronic kidney disease stages 1-3…
-
CLINICAL_TRIALS safety_alert · 2014-11-04Clinical Trial Update: Evaluation of the Risk of NSF Following MultiHance Injection in Patients With Chronic Kidney Disease
A completed clinical trial assessing the risk of nephrogenic systemic fibrosis after MultiHance (gadoteridol) administration in patients wit…
-
CLINICAL_TRIALS trial_result · 2014-11-04Clinical Trial Update: Evaluation of the Risk of NSF Following ProHance Injection in Patients With Chronic Kidney Disease
This completed study evaluated the risk of nephrogenic systemic fibrosis after injecting ProHance in people with chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Evaluation of the Integrated Home Dialysis Model
Completed clinical trial evaluating an integrated home dialysis model for chronic kidney disease. The study was sponsored by Princess Alexan…
-
CLINICAL_TRIALS trial_result · 2014-10-27Clinical Trial Update: Fu-zheng-qu-zhuo Oral Liquid Improves Renal Function in Patients of CKD Stage 3 and 4 [Phase 2]
A Phase 2 clinical trial reports that Fu-zheng-qu-zhuo Oral Liquid improves renal function in patients with chronic kidney disease stages 3 …